Daar is geen geneesmiddel vir Alzheimer se siekte nie, maar daar is verskeie behandelingsopsies beskikbaar om die simptome te help beheer en die vordering van die siekte te vertraag.
Sommige van hierdie behandelings sluit in:
1. Medisyne: Daar is verskeie medisyne beskikbaar wat kan help om die simptome van Alzheimer se siekte te beheer.
Dit sluit cholinesterase-remmers in, soos donepezil, rivastigmien en galantamien, wat kan help om kognitiewe funksie en geheue te verbeter.
Memantine is nog ' n medikasie wat kan help met kognitiewe funksie en gedragsimptome.
2. Veranderings in lewenstyl: Gereelde fisiese oefening, 'n gesonde dieet en die handhawing van sosiale verbindings kan help om die algemene gesondheid en welsyn van mense met Alzheimer se siekte te verbeter.
3. Kognitiewe en gedragsterapieë: Kognitiewe terapieë, soos kognitiewe stimulasie-terapie, kan help om kognitiewe funksie en geheue by mense met Alzheimer se siekte te verbeter.
Gedragsterapieë, soos kognitiewe gedragsterapie, kan help om gedragsimptome te bestuur en die lewensgehalte te verbeter.
4. Ondersteunende sorg: Ondersteunende sorg, soos bedryfsterapie, spraakterapie en fisioterapie, kan mense met Alzheimer se siekte help om hulle onafhanklikheid en funksie so lank as moontlik te behou.
5. Kliniese proewe: Deelname aan kliniese proewe vir nuwe behandelings en terapieë kan toegang tot nuutste behandelings bied en help om by te dra tot die ontwikkeling van nuwe behandelings vir Alzheimer se siekte.
Dit is belangrik om nou saam te werk met 'n gesondheidsorgverskaffer om 'n geïndividualiseerde behandelingsplan vir Alzheimer se siekte te ontwikkel, aangesien die behoeftes en simptome van elke persoon kan wissel.
Daarbenewens is dit noodsaaklik om emosionele ondersteuning en sorg te voorsien vir beide die persoon met Alzheimer se siekte en hulle versorgers.
Kumar A, Singh A, Aggarwal A: Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview. Indian J Exp Biol. 2017, 55 (2): 63-73.
Sutor B, Rasmussen KG: Electroconvulsive therapy for agitation in Alzheimer disease: a case series. J ECT. 2008, 24 (3): 239-41.
Boada M, Ramos-Fernández E, Guivernau B, Muñoz FJ, Costa M, Ortiz AM, Jorquera JI, Núñez L, Torres M, Páez A: Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study. Neurologia. 2016, 31 (7): 473-81.
Golde TE: The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol. 2005, 15 (1): 84-7.
Giacobini E: Therapy of Alzheimer disease: symptomatic or neuroprotective? J Neural Transm Suppl. 1994, 43 (): 211-7.
Haussmann R, Donix M: [Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]. Nervenarzt. 2017, 88 (1): 40-45.
Verwerping van verantwoordelikheid: mediese
Hierdie webwerf word slegs vir opvoedkundige en inligtingsdoeleindes verskaf en vorm nie die verskaffing van mediese advies of professionele dienste nie.
Die inligting wat verskaf word, moet nie gebruik word om 'n gesondheidsprobleem of siekte te diagnoseer of te behandel nie, en diegene wat persoonlike mediese advies soek, moet 'n gelisensieerde dokter raadpleeg.
Let asseblief daarop dat die neurale netwerk wat antwoorde op die vrae genereer, veral onakkuraat is wanneer dit kom by numeriese inhoud. Byvoorbeeld, die aantal mense wat met 'n spesifieke siekte gediagnoseer is.
Soek altyd die advies van jou dokter of ander gekwalifiseerde gesondheidsorgverskaffer oor 'n mediese toestand. Moet nooit professionele mediese advies ignoreer of vertraag om dit te soek as gevolg van iets wat jy op hierdie webwerf gelees het nie. As jy dink jy kan 'n mediese noodgeval hê, bel 911 of gaan onmiddellik na die naaste noodkamer. Geen dokter-pasiënt verhouding word geskep deur hierdie webwerf of die gebruik daarvan nie. Nie BioMedLib of sy werknemers, of enige bydraer tot hierdie webwerf, maak enige voorstellings, uitdruklik of implisiet, met betrekking tot die inligting wat hierin verskaf word of die gebruik daarvan.
Verwerping van verantwoordelikheid: kopiereg
Die Digital Millennium Copyright Act van 1998, 17 U.S.C. § 512 (die DMCA) bied hulp vir kopiereg eienaars wat glo dat materiaal wat op die Internet verskyn, hul regte onder die Amerikaanse kopiereg wet oortree.
As u in goeie trou glo dat enige inhoud of materiaal wat in verband met ons webwerf of dienste beskikbaar gestel word, u kopiereg oortree, kan u (of u agent) vir ons 'n kennisgewing stuur om te versoek dat die inhoud of materiaal verwyder word, of toegang daartoe geblokkeer word.
Kennisgewings moet skriftelik per e-pos gestuur word (sien afdeling "Kontak" vir e-posadres).
Die DMCA vereis dat u kennisgewing van beweerde inbreuk op outeursreg die volgende inligting bevat: (1) beskrywing van die kopieregbeskermde werk wat die onderwerp van beweerde inbreuk is; (2) beskrywing van die beweerde inbreuk op inhoud en inligting wat genoeg is om ons in staat te stel om die inhoud op te spoor; (3) kontakinligting vir u, insluitend u adres, telefoonnommer en e-posadres; (4) 'n verklaring deur u dat u op 'n goeie geloof glo dat die inhoud op die manier waarop u gekla het nie deur die outeursreg eienaar, of sy agent, of deur die werking van enige wet gemagtig is nie;
(5) 'n verklaring deur u, onderteken onder strawwe van meineed, dat die inligting in die kennisgewing akkuraat is en dat u die gesag het om die outeursregte wat beweer word, af te dwing;
en (6) 'n fisiese of elektroniese handtekening van die outeursreg-eienaar of 'n persoon wat gemagtig is om namens die outeursreg-eienaar op te tree.
As u nie al die bogenoemde inligting insluit nie, kan dit lei tot 'n vertraging in die verwerking van u klag.
Kontak
Stuur asseblief vir ons 'n e-pos met enige vrae / voorstelle.
How to treat alzheimer?
There is no cure for Alzheimer's disease, but there are several treatment options available to help manage the symptoms and slow the progression of the disease.
Some of these treatments include:
1. Medications: There are several medications available that can help manage the symptoms of Alzheimer's disease.
These include cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, which can help improve cognitive function and memory.
Memantine is another medication that can help with cognitive function and behavioral symptoms.
2. Lifestyle changes: Engaging in regular physical exercise, eating a healthy diet, and maintaining social connections can help improve overall health and well-being for people with Alzheimer's disease.
3. Cognitive and behavioral therapies: Cognitive therapies, such as cognitive stimulation therapy, can help improve cognitive function and memory in people with Alzheimer's disease.
Behavioral therapies, such as cognitive behavioral therapy, can help manage behavioral symptoms and improve quality of life.
4. Supportive care: Supportive care, such as occupational therapy, speech therapy, and physical therapy, can help people with Alzheimer's disease maintain their independence and function as long as possible.
5. Clinical trials: Participating in clinical trials for new treatments and therapies can provide access to cutting-edge treatments and help contribute to the development of new treatments for Alzheimer's disease.
It is important to work closely with a healthcare provider to develop an individualized treatment plan for Alzheimer's disease, as the needs and symptoms of each person can vary.
Additionally, it is essential to provide emotional support and care for both the person with Alzheimer's disease and their caregivers.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ongeveer
BioMedLib gebruik outomatiese rekenaars (masjienleeralgoritmes) om vraag-en-antwoord-pare te genereer.
Ons begin met 35 miljoen biomediese publikasies van PubMed/Medline. Ook webbladsye van RefinedWeb.
Sien "Referensies" ook "Verwerping van aanspreeklikheid".
